T

Turnstone Biologics Corp
NASDAQ:TSBX

Watchlist Manager
Turnstone Biologics Corp
NASDAQ:TSBX
Watchlist
Price: 0.355 USD Market Closed
Market Cap: 8.2m USD

Net Margin
Turnstone Biologics Corp

0%
Current
-52%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-63m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Turnstone Biologics Corp
Glance View

Market Cap
8.2m USD
Industry
Biotechnology

Turnstone Biologics Corp is a US-based company operating in Biotechnology industry. The company is headquartered in La Jolla, California and currently employs 108 full-time employees. The company went IPO on 2023-07-21. Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The firm is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across multiple solid tumors. Its selected TIL approach focuses on selecting and expanding potent tumor-reactive T cells to overcome the limitations of bulk TILs. Its pipeline includes TIDAL-01 and TIDAL-02. Its lead selected TIL product candidate, TIDAL-01, utilizes an unbiased identification and functional screening process to isolate and selectively expand the breadth of tumor-reactive TILs from the patient’s tumor. Its next selected TIL program, TIDAL-02, is being designed to encompass a streamlined manufacturing process for tumor-reactive T cells and additional modifications to enhance TIL quality and function.

TSBX Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-63m
/
Revenue
0
What is the Net Margin of Turnstone Biologics Corp?

Based on Turnstone Biologics Corp's most recent financial statements, the company has Net Margin of 0%.

Back to Top